The largest database of trusted experimental protocols

Peg lipid

Manufactured by Avanti Polar Lipids
Sourced in United States

PEG-lipid is a type of lipid compound that incorporates polyethylene glycol (PEG) into its structure. PEG-lipids are used in the formulation of liposomal and other lipid-based drug delivery systems to improve the pharmacokinetic properties of the encapsulated or associated drugs.

Automatically generated - may contain errors

3 protocols using peg lipid

1

Lipid Nanoparticle Formulation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LNPs used in this study comprised a lipid mixture consisting of C12-200 (amino lipid, Axolabs), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), DMPE-mPEG2000 (PEG-lipid), and cholesterol at a 52.2:15.6:8.7:23.6 mass ratio, respectively (DOPE, PEG-lipid, and cholesterol from Avanti Polar Lipids). LNPs were prepared by rapid microfluidic mixing (Precision NanoSystems) of mRNA and sgRNA in acetate buffer at pH 4.0 with the lipid mixture suspended in ethanol (3:1 aqueous to organic volume ratio). After mixing, LNPs were diluted and dialyzed into PBS, concentrated as needed using 100k MWCO spin cartridges (Amicon), and 0.2 µm sterile filtered. mRNA production and sequence optimization was performed as previously described32 (link),59 (link). gRNA was procured from Synthego (sRGN Alb-T1), Avecia (SpyCas9 Alb-T1), and Agilent (modified sRGN Alb-T1 constructs). LNPs were characterized by dynamic light scattering (DLS) using a Wyatt Nanostar, Ribogreen (Thermo Fisher Scientific), for endotoxin (Endosafe, Charles River), by UPLC (Thermo Fisher Scientific), and cryoTEM (MIT) assays.
+ Open protocol
+ Expand
2

Giant Unilamellar Vesicle Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPG), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N’-carboxyfluorescein] (DSPE-PEG(2000) CF), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(polyethylene glycol)-2000] (DSPE-PEG(2000) Biotin. Hereafter referred to as “PEG lipid” for short) were purchased from Avanti Polar Lipids (Alabaster, USA). Cholesterol was purchased from Nacalai Tesque (Kyoto, Japan). These lipids were stored in a freezer at -20°C to avoid any degradation of lipids and dissolved in chloroform (100mg/mL concentration) prior to experiments. Fluorescent proteins, transferrin from human serum Alexa Fluor 647 conjugate (TA647, for short) and Alexa Fluor 488 Fluorescent Streptavidin Conjugates (Avidin AF488) were purchased from Invitrogen (Carlsbad, USA). Aqueous solution encapsulated in giant vesicles contains 50 mM HEPES-KOH (pH 7.6), 200 mM sucrose, and 1.5 μM TA647. Buffer solution contains 50 mM HEPES-KOH (pH 7.6), 200 mM glucose.
+ Open protocol
+ Expand
3

Chikungunya Virus mRNA-LNP Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The production of mRNA-LNP was described previously (Zhang et al., 2020 (link)). Briefly, RNA was produced using T7 RNA polymerase on linearized plasmids (pok12-5′UTR-CHIKV-E2-E1-3′UTR) encoding CHIKV E2-E1 protein. The UTP was substituted with 1 ​mψ (1-methylpseudouridine-5′-triphosphate) (TriLink BioTechnologies) to improve protein expression. Then the transcriptional RNA was added with Cap1 and poly(A) tails by using the Vaccinia Capping System and E. coli poly(A) polymerase (New England Biolabs), respectively. The mRNA was stored at −80 ​°C freezer.
For LNP production, D-Lin-MC3-DMA (MedChemExpress), DSPC (Avanti Polar Lipids), cholesterol (Sigma), and PEG-lipid (Avanti Polar Lipids) were solubilized in ethanol respectively and mixed with a molar ratio of 50:10:38.5:1.5. The lipid mixture was then mixed with an aqueous buffer (50 ​mmol/L citrate buffer [pH 4.0]), reaching the final lipid concentration of 7.37 ​mg/mL. Then the lipid mixture and mRNA were added into the NanoAssemblr™ with the volume ratio of 1:3 to obtain mRNA-LNP. Then the diluted LNP-encapsulated mRNA samples were concentrated to appropriate volume and passed through 0.22 ​μm filters. The produced mRNA-LNP was stored at 4 ​°C until use. The encapsulation efficiency was measured with the Quant-iT RiboGreen RNA Assay Kit (Life Technologies) using a microplate reader.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!